Promising approach to improve outcome for children with high-risk leukemia
Sunday, November 17, 2013 - 21:00
in Health & Medicine
Results from a new study is showing that a drug withdrawn from the market in 2010 may enhance the effectiveness of bone marrow transplants for select pediatric leukemia patients. Combining the drug gemtuzumab ozogamicin (GO) with conventional chemotherapy may improve the outcome of bone marrow transplantation for some children battling high-risk acute myeloid leukemia (AML).